IFN-γ inducibility of class II transactivator is specifically lacking in human tumour lines: Relevance to retinoblastoma protein rescue of IFN-γ inducibility of the HLA class II genes

Immunology and Cell Biology

Volumn 75, Issue 4, 1997, Pages 325-332

  Lu, Yanmei ^a,b   Tschickardt, Michael E ^a   Schmidt, Brian J ^a   Blanck, George ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b GENENTECH INC   (United States)

Author keywords

Class II transactivator; IFN ; MHC class II expression; Retinoblastoma protein; Tumorigenesis

Indexed keywords

GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; RETINOBLASTOMA PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFORMATION; HLA SYSTEM; HUMAN; HUMAN CELL;

EID: 0030954856     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.50     Document Type: Article

References (42)

1. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins (review). Science 1994; 264: 1415-21.
2. Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by alpha and gamma, and is likely to autoregulate the p91 gene. EMBO J. 1994; 13: 158-67.
3. Jahnke A, Johnson JP. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and -gamma is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 alpha (p91) that can be activated by both -gamma and -alpha. FEBS Lett. 1994; 354: 220-6.
4. Hou J, Baichwal V, Cao Z. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc. Natl Acad. Sci. USA 1994; 91: 11 641-5.
5. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994; 265: 106-9.
6. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MCH class II transactivator mutated in hereditary MCH class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135-46.
7. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM. Activation of class II MHC genes requires both X-box region and the class II transactivator CIITA. Immunity 1995; 2: 533-43.
8. Cresswell P. Assembly, transport, and function of MHC class II molecules (Review). Annu. Rev. Immunol. 1994; 12: 259-93.
9. Ting JP. Current concepts in DRA gene regulation (review). Immunol. Res. 1993; 12: 65-77.
10. Morris P, Shaman J, Attaya M et al. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 1994; 368: 551-4.
11. Sloan VS, Cameron P, Porter G et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995; 375: 802-6.
12. Fling SP, Arp B, Pious D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 1994; 368: 554-8.
13. Lu Y, Ussery GD, Jacim M, Tschickardt M, Boss JM, Blanck G. Retinoblastoma protein regulation of surface CD74 (invariant chain) expression in breast carcinoma cells. Mol. Immunol. 1994; 31: 1365-8.
14. Lu Y, Ussery GD, Muncaster MM, Gallie BL, Blanck G. Evidence for retinoblastoma protein (RB) dependent and independent -gamma responses: RB coordinately rescues -gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogene 1994; 9: 1015-19.
15. Lu Y, Boss JM, Hu S-H, Xu H-J, Blanck G. Apoptosis independent retinoblastoma protein rescue of HLA class II mRNA -gamma inducibility in non-small cell lung carcinoma: Lack of surface HLA-DR expression associated with a specific defect in HLA-DRA induction. J. Immunol. 1996; 156: 2495-502.
16. Tschickardt ME, Lu Y, Jacim M et al. RB and a novel E2F binding protein in MHC class II deficient B-cell lines and normal -gamma induction of the class II transactivator CIITA in class II non-inducible RB-defective tumor lines. Int. J. Cancer 1995; 62: 461-5.
17. Schmidt B, Carter SE, Berry DE, Blanck G. Vitamin D3 reduces the apoptotic effect of IFN-gamma but does not facilitate HLA class II inducibility in RB-defective cells. Cancer Lett. 1996; 110: 169-76.
18. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7.
19. Van den Eynde B, Lethe B, Van Pel A, De Plaen E, Boon T. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 1991; 173: 1373-84.
20. Ostrand-Rosenberg S, Thakur A, Clements V. Rejection of mouse sarcoma cells after transfection of MHC class II genes. J. Immunol. 1990; 144: 4068-71.
21. Fearon ER, Pardoll DM, Itaya T et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 1990; 60: 397-403.
22. Schultz KR, Klarnet JP, Gieni RS, Hayglass KT, Greenberg PD. The role of B cells for in vivo T cell responses to a friend virus-induced leukemia. Science 1990; 249: 921-3.
23. Baskar S, Azarenko V, Garcia Marshall E, Hughes E, Ostrand-Rosenberg S. MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice. Cell. Immunol. 1994; 155: 123-33.
24. Baskar S, Glimcher L, Nabavi N, Jones RT, Ostrand-Rosenberg S. Major histocompatibility complex class II + B7-1 + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 1995; 181: 619-29.
25. Mongini C, Lockhart MS, Waldner CI et al. Enhancement of anti-tumor immunity in syngeneic mice after MHC class II gene transfection. Br. J. Cancer 1996; 74: 258.
26. Helin K, Harlow E. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 1993; 3: 43-6.
27. Kim SJ, Wagner S, Liu F, O'Reilly MA, Robbins PD, Green MR. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 1992; 358: 331-1.
28. Singh P, Coe J, Hong W. A role of retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 1995; 374: 562-5.
29. Muncaster MM, Cohen BL, Phillips RA, Gallie BL. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res. 1992; 52: 654-61.
30. Shimizu E, Coxon A, Otterson GA et al. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 1994; 9: 2441-8.
31. Blanck G, Lok M, Kok K, Downie E, Korn JH, Strominger JL. Gamma-interferon induction of HLA class II mRNAs in dermal fibroblasts studied by RNase protection analysis. Hum. Immunol. 1990; 29: 150-6.
32. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 1982; 2: 1044-51.
33. Chin KC, Mao C, Skinner C et al. Molecular analysis of G1B and G3A -gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1995; 1: 687-97.
34. Chang CH, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 1995; 181: 765-7.
35. Reimold AM, Kara CJ, Rooney JW, Glimcher LH. Transforming growth factor beta 1 repression of the HLA-DR alpha gene is mediated by conserved proximal promoter elements. J. Immunol. 1993; 151: 4173-82.
36. Woolfrey AE, Andersen LC, Shewey L, Chung J, Nepom GT. Analysis of differential HLA-DQB expression in autologous B cell lines. J. Leukoc. Biol. 1993; 53: 697-706.
37. Barr CL, Saunders GF. Interferon-gamma inducible regulation of the human invariant chain gene. J. Biol. Chem. 1991; 266: 3475-81.
38. Lew DJ, Decker T, Strehlow I, Darnell JE. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol. Cell. Biol. 1991; 11: 182-91.
39. Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 1994; 180: 1367-74.
40. McKendry R, John J, Flavell D, Muller M, Kerr IM, Stark GR. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc. Natl Acad. Sci. USA 1991; 88: 11 455-9.
41. Pellegrini S, John J, Shearer M, Kerr IM, Stark GR. Use of a selectable marker regulated by alpha Interferon to obtain mutations in the signalling pathway. Mol. Cell. Biol. 1989; 9: 4605-12.
42. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis (review). Cell 1990; 61: 759-67.